PTPRC and urinary bladder cancer: This patient is included in the analysis as the CTCs were CD45−, while cells from AML were found to be uniformly CD45+; FISH analysis performed on these CD45− CTCs confirmed genomic alterations consistent with bladder cancer, further discussed below.